Meilleurs médecins de cancer du cerveau à l'étranger — Page 4

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Spécialisé dans la prise en charge des tumeurs cérébrales à l'hôpital international Medicalpoint, avec une solide formation en oncologie obtenue à l'université Hacettepe.

• Expérience dans le traitement de divers cancers, y compris les tumeurs cérébrales
• Formé à l'université Hacettepe, un centre d'oncologie de premier plan
• Membre de l'ESMO et de l'Association turque d'oncologie médicale

Le Dr Jablonski-Perec a suivi une formation au célèbre Sloan-Kettering Cancer Center de New York et est devenue chef du service d'oncologie au Hadassah Medical Center.

• Plus de _doctor_106_années_ à la tête de services d'oncologie et de centres de traitement
• Professeur d'oncologie à l'Université hébraïque, l'une des meilleures facultés de médecine d'Israël
• Chef du centre de traitement du cancer du sein depuis 1998
• Membre de plusieurs sociétés internationales de lutte contre le cancer
• Lauréate d'une prestigieuse bourse de la faculté de médecine Hadassah

Pionnier dans la recherche sur les syndromes neurologiques paranéoplasiques – le Dr Graus a défini leurs critères diagnostiques. Travaille à l'Hôpital Quiron de Barcelone.

• 44 années d'expérience d'expérience en neuro-oncologie
• Spécialisé dans les gliomes et les lymphomes cérébraux primitifs
• Ancien chef de neurologie à l'Hospital Clinic
• Fondateur et ancien président de l'EANO
• Doctorat honorifique de l'Université de Lyon

Spécialisé dans les chirurgies endoscopiques et l'ablation des tumeurs cérébrales au Samsung Medical Center, l'un des principaux hôpitaux de neurochirurgie en Corée du Sud.

• Traite les patients pédiatriques et adultes
• Expertise dans les tumeurs cérébrales bénignes et malignes
• Compétent dans les techniques de radiochirurgie

La Prof. Elke Jaeger est l'une des meilleures oncologues d'Allemagne selon le classement Focus, spécialisée dans les sarcomes à la clinique Nordwest.

• 41 années d'expérience d'expérience en oncologie et hématologie
• Chef du service d'oncologie et d'hématologie à la clinique Nordwest
• Spécialiste reconnue des sarcomes

La professeure Gul Alco est une experte en radio-oncologie à l'Université Medipol d'Istanbul avec plus de _doctor_7679_ années d'expérience.

• Spécialisée dans la radiothérapie des tumeurs cérébrales
• Professeure aux universités Demiroglu Bilim et Medipol
• Diplômée de la faculté de médecine de l'Université d'Istanbul

Le professeur associé Nail Paksoy apporte une vaste expertise en oncologie acquise à l'Institut d'oncologie de l'Université d'Istanbul et à l'hôpital Medipol Bahçelievler.

• Certifié par l'ESMO en oncologie médicale
• A participé à plus de 8 essais cliniques internationaux sur des cancers avancés
• A publié plus de 30 articles de recherche sur des traitements innovants contre le cancer
• Spécialisé dans les thérapies ciblées et les approches d'oncologie de précision

Le Dr Topcu a été formé dans des centres de cancérologie de premier plan, notamment MD Anderson et Sunnybrook, se spécialisant dans les cas oncologiques complexes.

• _doctor_9372_années_ d'expérience en oncologie médicale
• Membre de l'ESMO et de l'ASCO – normes mondiales en oncologie
• Travaille à l'hôpital universitaire Biruni avec une technologie de pointe
• Spécialisé dans les cancers du sein, du poumon et du cerveau

La Prof. Didem Karacetin est spécialisée dans les tumeurs cérébrales et apporte 32 années d'expérience d'expertise en radio-oncologie au sein de l'hôpital universitaire Biruni.

• Résidence au célèbre hôpital Princess Margaret de Toronto
• Chef des départements de radio-oncologie dans de grandes universités turques
• Titulaire d'un master en phytothérapie pour les soins complémentaires contre le cancer
• Experte en techniques de curiethérapie et de radiothérapie peropératoire

Le Dr Elnur Sahibov est spécialisé dans le traitement du cancer du cerveau à l'hôpital Emsey, avec une formation en oncologie radiothérapique de l'Université de Marmara.

• Spécialisation en oncologie radiothérapique obtenue à l'Université de Marmara
• Membre d'une équipe chirurgicale dédiée aux cas de cancer du cerveau
• Plus d'une décennie d'éducation et de formation médicale

Le professeur Pietro Mortini est spécialisé dans les chirurgies cérébrales mini-invasives, offrant des opérations plus précises et des temps de récupération plus courts à l'Institut scientifique San Raffaele.

• d'expérience avec plus de 1 100 traitements effectués
• Directeur de l'unité de neurochirurgie expérimentale à San Raffaele
• Utilise la neuronavigation avancée et le neuromapping pour plus de précision
• Professeur invité à l'Université George Washington

Le Dr Ayşe İrem Yasin est oncologue médical à l'hôpital de district Medipol Acıbadem à Istanbul. Elle détient le prestigieux certificat du conseil de l'ESMO. Le Dr Yasin est spécialisée dans les tumeurs solides, notamment les cancers du sein, du poumon et gastro-intestinaux. Elle traite des cas complexes tels que le carcinome à cellules de Merkel et les cancers de primitif inconnu.

• Formée à la Harvard Medical School, à la Cleveland Clinic et à l'hôpital universitaire de Bâle.
• A effectué un stage d'observation clinique dans l'unité de cancer du sein à Novare, en Italie.
• Traite les tumeurs malignes du cerveau et du SNC, les sarcomes des tissus mous et les cancers urologiques.
• Travaille dans un établissement accrédité par la JCI et équipé du système robotique da Vinci.

Le Dr Atakan Topcu est oncologue médical à l'hôpital Medipol Acibadem District d'Istanbul. Il est spécialisé dans le traitement des tumeurs solides, notamment les cancers du poumon, du sein et colorectal. Le Dr Topcu est professeur associé et auteur de plus de 50 publications scientifiques évaluées par des pairs. Il siège au comité de rédaction de la revue médicale BMC Cancer.

• Expertise en immunothérapie, thérapies ciblées et oncologie gériatrique.
• Traite la dénutrition liée au cancer, la cachexie et la sarcopénie.
• Membre actif de la Société européenne d'oncologie médicale (ESMO).
• Travaille dans un hôpital accrédité par la JCI, spécialisé dans les traitements oncologiques avancés.

Chef de l'enseignement à l'hôpital régional de Puerto Vallarta – Le Dr Perez allie expertise médicale et accent sur l'éducation et les soins aux patients.

• Médecin généraliste avec _doctor_8330_ années d'expérience en cabinet privé
• Spécialisé dans les procédures chirurgicales mini-invasives
• Certifié en biomagnétisme par l'Institut supérieur de biomagnétisme
• Expérience dans les traitements dermatologiques et au laser

Dirige le département de neurochirurgie de la Charité – l'un des meilleurs hôpitaux d'Allemagne, réalisant plus de 4 000 neurochirurgies par an.

• Spécialisé dans les troubles cérébrovasculaires et les tumeurs cérébrales
• Lauréat du prix de recherche pour les jeunes neurochirurgiens
• Plus de _doctor_896_ans_ à la tête d'équipes neurochirurgicales
• Expert en neurochirurgie fonctionnelle et en gestion de la douleur